-
Researchers launch race to develop sustainable COVID-19 vaccine delivery
expresspharma
May 08, 2020
Backed by the Shakti Sustainable Energy Foundation, experts from the University of Birmingham and Heriot-Watt University, Edinburgh are joining forces with non-profit, commercial and academic partners to begin investigating ...
-
Arcturus, Catalent Partner to Manufacture COVID-19 Vaccine
contractpharma
May 05, 2020
The manufacture of LUNAR-COV19 at Catalent’s drug substance biomanufacturing facility in Madison, WI will support human clinical studies.
-
CEPI Inks COVID-19 Vax Pact with Clover Bio
contractpharma
May 05, 2020
Becomes ninth global COVID-19 vaccine development project that CEPI has signed since Jan 23, 2020.
-
Inovio Pharmaceuticals boosts Covid-19 vaccine manufacturing
pharmaceutical-technology
May 04, 2020
Inovio Pharmaceuticals has signed an agreement with German contract manufacturer Richter-Helm BioLogics for large-scale production of Covid-19 DNA vaccine candidate, INO-4800.
-
£14m funding to support rapid COVID-19 vaccine manufacturing scale up
europeanpharmaceuticalreview
April 30, 2020
The UK Bioindustry Association industry-led vaccine manufacturing group has welcomed a £14 million investment to support COVID-19 vaccine manufacturing.
-
AstraZeneca and Oxford University partner on Covid-19 vaccine
pharmaceutical-technology
April 30, 2020
AstraZeneca has signed an agreement with the University of Oxford to develop and distribute the university’s Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
-
Clover Biopharmaceuticals gets CEPI funding for Covid-19 vaccine
harmaceutical-technology
April 30, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has signed an agreement with Clover Biopharmaceuticals Australia, a subsidiary of China-based Sichuan Clover Biopharmaceuticals, to support the development of a Covid-19 vaccine candidate.
-
University of Queensland reports positive findings on Covid-19 vaccine
pharmaceutical-technology
April 30, 2020
The University of Queensland in Australia has reported positive findings from early preclinical testing of its Covid-19 vaccine candidate.
-
China's inactivated COVID-19 vaccine enters 2nd-phase clinical trial
chinadaily
April 27, 2020
China's inactivated COVID-19 vaccine entered the second phase of clinical trial on April 24, according to its developers.
-
HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine
b3cnewswire
April 23, 2020
HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner